Logo
Login
$CHRS
$1.07 +$0.06 (5.94%) Close

Ownership

13F as of Q2 2026 · 154.5M shares outstanding

Who owns CHRS?

By type of holder
Institutions 45.4% Insiders 1.3% Everyone else 53.3%
Concentration Top 10 holders own 32.1%
Timothy G. Youngquist 2020 Irrevocable Trust 8.5% · BlackRock, Inc. 7.8%
Institutional ownership
45.4%
-0.9 pts vs last qtr
Institutional holders
145
-13 vs last qtr
Net shares bought
−1.4M
by institutions in Q2 2026
New / sold out
10 / 23
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • BlackRock, Inc. +1.6M
  • Timothy G. Youngquist 2020 Irrevocable Trust +759.8K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Tang Capital Management LLC SOLD OUT −1.9M
  • Propel Bio Management, LLC SOLD OUT −1.4M

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Coherus Oncology Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2017–FY2025
+120.5%
+10.39% a year
Each share's claim on the business
−54.6%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $330M
over 9 fiscal years
Diluted shares, split-adjusted
51.5M84.9M118.3M2017: 53.1M shares'172018: 65.0M shares'182019: 73.2M shares'192020: 83.5M shares'202021: 75.4M shares'212022: 77.6M shares'222023: 94.2M shares'232024: 114.6M shares'242025: 117.1M shares'25
Buybacks Stock-based comp
$0$25.7M$51.4M2017 buybacks: $02017 stock comp: $33.4M'172018 buybacks: $02018 stock comp: $34.8M'182019 buybacks: $02019 stock comp: $33.6M'192020 buybacks: $02020 stock comp: $38.2M'202021 buybacks: $02021 stock comp: $51.4M'212022 buybacks: $02022 stock comp: $50.7M'222023 buybacks: $02023 stock comp: $43.1M'232024 buybacks: $02024 stock comp: $27.8M'242025 buybacks: $02025 stock comp: $17.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years56% 3–5 years3% 1–3 years8% Under 1 year33%
Quarterly turnover
9.0%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting CHRS on Form 13F
TG
Timothy G. Youngquist 2020 Irrevocable Trust
Shares
13.1M
% of company
8.45%
Change vs last qtr
+759.8K (+6.2%)
Held since
Q4 '25
B
BlackRock, Inc.
Shares
12.0M
% of company
7.77%
Change vs last qtr
+1.6M (+15.8%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Coherus Oncology Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting CHRS on Form N-PORT; together they hold 13.4% of the company
VT
Vanguard Total Stock Market Index Fund
Vanguard Index Funds
Position value
$5.54M
% of company
2.56%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Russell 2000 ETF
iShares Trust
Position value
$4.5M
% of company
2.08%
% of the fund
0.01%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Coherus Oncology Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
LD
Lanfear Dennis M
Insider
Shares
1.6M
% of company
1.01%
Change vs last qtr
—
Held since
—
MB
McMichael Bryan J
Insider
Shares
133.7K
% of company
0.09%
Change vs last qtr
—
Held since
—

8 more holders behind a free account

See every insider and 5%+ holder of Coherus Oncology Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans